⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 3, 2024Open Access

Supplementary Figure 4 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate

Priyanka Hirani Jacqueline McDermott Vinothini Rajeeve Pedro R. Cutillas J. Louise Jones Daniel J. Pennington Thomas N. Wight Salvatore Santamaria Kimberly M. Alonge Oliver M.T. Pearce

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 4 shows different method of TIP analysis and the TIPs from different subsets of tissues.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hirani et al. (2024) studied this question.

synapsesocial.com/papers/68e709f8b6db6435876838ec https://doi.org/10.1158/2767-9764.25534430.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 4 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate2024
2Supplementary Figure 6 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate2024
3Supplementary Figure 6 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate2024
4Supplementary Figure 8 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate2024
5Supplementary Figure 8 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate2024

More related papers

Supplementary Figure 2 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate2024
Supplementary Figure 5 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate2024
Supplementary Figure 5 from Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate2024